The FDA is directing Covid-19 vaccine manufacturers to update their formulations to target the KP.2 strain of the virus, citing higher circulation levels of that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.